KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Adaptive Biotechnologies (ADPT) Other Gross PP&E Adjustments (2018 - 2025)

Adaptive Biotechnologies' Other Gross PP&E Adjustments history spans 8 years, with the latest figure at $85.5 million for Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments fell 2.51% year-over-year to $85.5 million; the TTM value through Dec 2025 reached $85.5 million, down 2.51%, while the annual FY2025 figure was $85.5 million, 2.51% down from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 was $85.5 million at Adaptive Biotechnologies, up from -$42.0 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $87.7 million in Q4 2024 and bottomed at -$92.9 million in Q2 2021.
  • The 5-year median for Other Gross PP&E Adjustments is -$49.8 million (2024), against an average of -$34.7 million.
  • The largest annual shift saw Other Gross PP&E Adjustments crashed 177.65% in 2021 before it surged 73.59% in 2022.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $30.1 million in 2021, then soared by 73.59% to $52.3 million in 2022, then soared by 61.49% to $84.4 million in 2023, then increased by 3.91% to $87.7 million in 2024, then dropped by 2.51% to $85.5 million in 2025.
  • Per Business Quant, the three most recent readings for ADPT's Other Gross PP&E Adjustments are $85.5 million (Q4 2025), -$42.0 million (Q3 2025), and -$43.3 million (Q2 2025).